Lv1
20 积分 2024-09-29 加入
What does BCL-2 do? From new molecular insights to the clinical implications
17天前
已完结
Cardio-safe degrader CT-03p degrades MCL-1 and overcomes venetoclax resistance in AML
3个月前
已完结
Canonical and non-canonical intricacies of MCL-1 in cancer
3个月前
已完结
Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain
4个月前
已完结
Canonical and non-canonical intricacies of MCL-1 in cancer
4个月前
已完结
Repotrectinib: First Approval
6个月前
已完结
Deciphering molecular specificity in MCL-1/BAK interaction and its implications for designing potent MCL-1 inhibitors
7个月前
已完结
皖公网安备34019202002308
